Today, most people who develop wet age-related macular degeneration (AMD) can retain much of their vision thanks to the advent of three treatment options, all administered through repeated ocular injections.
By Dr. Steve Rose on May 23, 2012 | 0 Comments
By Dr. Steve Rose on April 5, 2012 | 6 Comments
I am pleased to report that Advanced Cell Technology (ACT) just received institutional review board approval to add Bascom Palmer Eye Institute in Miami, Florida, as a clinical trial site for its stem-cell-derived treatment for people with dry age-related macular degeneration (AMD). Bascom Palmer has been ranked by U.S. News & World Report as the best ophthalmology hospital in the U.S. for the last eight years, so they are no doubt a valuable addition to the study.
Continue Reading…
By Dr. Steve Rose on March 28, 2012 | 0 Comments

Tel Aviv, Israel
Now that I’m back from my trip to Israel, I wanted to offer a couple more posts about my visit, the first covering a fascinating research conference in Tel Aviv.
Continue Reading…
By Dr. Steve Rose on March 15, 2012 | 0 Comments

The Wailing Wall, Israel
So, my prayers were answered. As I mentioned in my last post, my luggage did not arrive with me in Israel, but, as the airlines promised, it did a day later, so I haven’t had to keep wearing the same clothes. Thank goodness.
Continue Reading…







Steve is highly respected for his expertise and tireless commitment to finding treatments and cures for vision-robbing retinal diseases.
As the Foundation's senior science writer, Ben writes science and research articles for the Foundation’s website, newsletters and Eye on the Cure blog.
As the Foundation's senior writer, Rich writes and edits content for all of the Foundation’s print and online publications, including its blog, Eye on the Cure. 
Rockin’ and Rollin’ for a Good Cause
By Dr. Steve Rose on June 1, 2012 | 0 Comments
Continue Reading…